Disclosures Under Regulation 46 of the LODR – Jenburkt Pharmaceuticals Limited

1	Details of Business
2	Terms and Conditions of appointment of Independent Directors
3	Composition of various committees of Board of Directors
4	Code of conduct of Board of Directors and Senior Management Personnel
5	Vigil mechanism/ Whistle Blower Policy
6	Policy on Materiality of Related Party Transactions and Dealing with Related Party Transactions
7	Familiarization programmes imparted to independent directors
8	Contact Details for grievance redressal
9	Notice of meeting of the Board of Directors
10	Financial Results
11	Annual Report
12	Shareholding pattern
13	Secretarial Compliance Report • 2021-22 • 2020-21 • 2019-20 • 2018-19
14	Policy for determination of materiality of events or information and contact details of key managerial personnel authorised for the purpose of determining materiality of an event or information
15	Disclosures to Stock Exchange
16	Annual Return
17	Newspaper Advertisements • Financial results • Notices to shareholders